p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes

被引:85
作者
Engelbrecht, A-M
Niesler, C
Page, C
Lochner, A
机构
[1] Univ Stellenbosch, Fac Hlth Sci, Dept Med Physiol & Biochem, ZA-7505 Tygerberg, South Africa
[2] Univ Stellenbosch, Dept Physiol Sci, ZA-7505 Tygerberg, South Africa
[3] Univ Stellenbosch, MRC, Diabet Res Grp, ZA-7505 Tygerberg, South Africa
关键词
ischaemia/reperfusion; MAPKs; PKB/Akt; apoptosis;
D O I
10.1007/s00395-004-0478-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rat neonatal ventricular myocytes exposed to simulated ischaemia and reperfusion (SI/R) were used as an in vitro model to delineate the role(s) of extracellular signal-regulated kinase (ERK), p38 and c-Jun NH2-terminal protein kinase (JNK), as well as PKB in apoptosis. Exposure of the myocytes to SI (simulated ischaemia - energy depletion induced by KCN and 2-deoxy-D-glucose) reduced cell viability, as measured by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay, and stimulated apoptosis as evidenced by caspase-3 activation and poly(ADP-ribose) polymerase (PARP) cleavage. However, morphological evidence of increased apoptosis, detected by staining with Hoechst 33342, was only seen in response to reperfusion. This suggests that although ischaemic conditions are sufficient to induce cellular markers of apoptosis (PARP cleavage and caspase-3 activation), reperfusion is required to complete the apoptotic pathway in these cells. Furthermore, SI resulted in a rapid, strong, biphasic activation of p38 concomitant with a weak and transient activation of the two ERK isoenzymes, p42/p44-MAPK. Reperfusion for 5 minutes resulted in a strong phosphorylation of p42/p44-MAPK, while no additional p38 activation was seen at this stage. On the other hand, p46/p54-MAPK (JNK) was phosphorylated in response to 5 minutes of reperfusion only and not during SI alone. A peak of PKB/Akt (Ser(473)) activity was seen within 5 minutes of exposure to SI, whereas PKB/Akt (Thr(308)) phosphorylation remained at the baseline level. Both PKB/Akt phosphorylation sites (Ser(473) and Thr(308)) were phosphorylated after 5 minutes of reperfusion. Inhibition of PI-3-kinase activity, using wortmannin, decreased phosphorylation on both sites during SI. However, only SI/R-induced PKB/Akt phosphorylation on Thr(308) was reduced by wortmannin. Myocytes pre-treated with SB203580, a p38-inhibitor, displayed a significant increase in cell viability [63.67 +/- 1.85 to 84.33 +/- 4.8% (p < 0.05)] and attenuation of the apoptotic index during SI/R [22.6 +/- 2.94% to 9 +/- 0.43% (p < 0.001)], while SP600125, a specific JNK inhibitor, caused a significant increase in caspase-3 activation [1.66 +/- 0.03 fold to 2.56 +/- 0.27 fold (p < 0.001)] and apoptotic index [22.6 +/- 2.94% to 32.75 +/- 6.13% (p < 0.05)]. However, PD98059, an ERK inhibitor, failed to affect apoptosis during SI/R. Inhibition of PI-3-kinase prevented the increase in mitochondrial viability usually observed during reperfusion. Interestingly, wortmannin caused a significant increase in PARP cleavage during reperfusion, but had no effect on caspase-3 activation or the apoptotic index. Our results suggest that p38 has a pro-apoptotic role while JNK phosphorylation is protective in our cell model and that these kinases act via caspase-3 to prevent or promote cell survival in response to SI/R-induced injury.
引用
收藏
页码:338 / 350
页数:13
相关论文
共 52 条
[1]   Role of mitogen-activated protein kinases in ischemia and reperfusion injury - The good and the bad [J].
Abe, J ;
Baines, CP ;
Berk, BC .
CIRCULATION RESEARCH, 2000, 86 (06) :607-609
[2]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[3]   Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B [J].
Anderson, KE ;
Coadwell, J ;
Stephens, LR ;
Hawkins, PT .
CURRENT BIOLOGY, 1998, 8 (12) :684-691
[4]   Myocyte cell death in the diseased heart [J].
Anversa, P ;
Kajstura, J .
CIRCULATION RESEARCH, 1998, 82 (11) :1231-1233
[5]   Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].
Bogoyevitch, MA ;
GillespieBrown, J ;
Ketterman, AJ ;
Fuller, SJ ;
BenLevy, R ;
Ashworth, A ;
Marshall, CJ ;
Sugden, PH .
CIRCULATION RESEARCH, 1996, 79 (02) :162-173
[6]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   Activation of the c-Jun N-terminal kinase/stress-activated protein kinase pathway by overexpression of caspase-8 and its homologs [J].
Chaudhary, PM ;
Eby, MT ;
Jasmin, A ;
Hood, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19211-19219
[9]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96
[10]   Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241